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Summary
Adhesion GPCRs are important regulators of conserved developmental processes and
represent an untapped pool of potential targets for drug discovery. The adhesion GPCR
Adgrg6 (Gpr126) has critical developmental roles in Schwann cell maturation and inner
ear morphogenesis in the zebrafish embryo. Mutations in the human ADGRG6 gene can
result in severe deficits in peripheral myelination, and variants have been associated
with many other disease conditions. Here, we review work on the zebrafish Adgrg6 sig-
naling pathway and its potential as a disease model. Recent advances have been made
in the analysis of the structure of the Adgrg6 receptor, demonstrating alternative struc-
tural conformations and the presence of a conserved calcium-binding site within the
CUB domain of the extracellular region that is critical for receptor function. Homozy-
gous zebrafish adgrg6 hypomorphic mutants have been used successfully as a whole-
animal screening platform, identifying candidate molecules that can influence signaling
activity and rescue mutant phenotypes. These compounds offer promise for further
development as small molecule modulators of Adgrg6 pathway activity.
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1 | INTRODUCTION
Adhesion G-protein-coupled receptors (aGPCRs) are the second larg-
est group of GPCRs, and are regulators of a wide range of develop-
mental and physiological processes. Like other GPCRs, aGPCRs have a
7-transmembrane domain, but are specifically characterized by their
very large extracellular region (ECR), which includes a GPCR
autoproteolysis-inducing (GAIN) domain (see Bondarev et al., 2020;
Langenhan, 2019; Morgan et al., 2019; Vizurraga, Adhikari, Yeung,
Yu, & Tall, 2020 for recent reviews). Adgrg6 (also known as Gpr126) is
one of the better-characterized aGPCRs. Initially described in
mammals (Moriguchi et al., 2004; Stehlik, Kroismayr, Dorfleutner,
Binder, & Lipp, 2004), it subsequently gained attention through the
analysis of mutant phenotypes in the zebrafish (Figure 1) (Geng
et al., 2013; Monk et al., 2009; Monk, Oshima, Jörs, Heller, &
Talbot, 2011), originally identified through mutagenesis screens for
morphology (Whitfield et al., 1996) or myelination (Pogoda
et al., 2006).
Adgrg6 has a conserved role in the formation of the myelin
sheath that insulates axons of the peripheral nervous system (PNS) in
vertebrates (Monk et al., 2009, 2011). The PNS is myelinated by
neural-crest-derived Schwann cells, and Adgrg6 is essential for
Schwann cell maturation and the initiation of myelination in both
zebrafish and mammals (Monk et al., 2009, 2011). HomozygousSarah Baxendale and Anzar Asad contributed equally to this work.
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adgrg6−/− mutant zebrafish show a reduction or loss of the Schwann
cell marker gene myelin basic protein (mbp) in the periphery (Figure 1b)
(Geng et al., 2013; Monk et al., 2009). In the PNS, adgrg6 is normally
expressed in Schwann cells (Monk et al., 2009): contact with the axon
is thought to trigger signaling through a canonical Gαs cascade, leading
to activation of adenylyl cyclase and the production of cAMP, in turn
activating Protein Kinase A and the expression of downstream target
genes, including oct6 and egr2 (Monk et al., 2009).
In addition to a reduction or loss of peripheral myelination, adgrg6
mutant zebrafish also have a striking inner ear phenotype (Figure 1)
(Geng et al., 2013; Monk et al., 2009; Whitfield et al., 1996). Epithelial
projections in the otic vesicle, which normally initiate the formation of
the semicircular canal ducts, overgrow and fail to fuse in the mutant,
resulting in an easily identifiable swelling of the ear (Diamantopoulou
et al., 2019; Geng et al., 2013). As in the PNS, Adgrg6 signaling in the
developing zebrafish ear appears to be triggered by cell–cell contact
and to act through cAMP, but here adgrg6 is expressed on both sides
of the fusing tissue (Geng et al., 2013). Many genes, including those
coding for extracellular matrix (ECM) proteins and synthases, together
with various developmental signaling pathway components, remain
expressed at abnormally high levels in the adgrg6−/− mutant ear (Geng
et al., 2013). These findings suggest that Adgrg6 signaling primarily
acts (directly or indirectly) to repress gene expression in the
developing ear.
The adgrg6 gene is expressed dynamically in the developing
embryo. In the zebrafish, the ear is a major site of expression, but
adgrg6 is also expressed in the neural crest and its derivatives
(Schwann cells, craniofacial cartilage), the heart, mesoderm, and
other tissues (Geng et al., 2013; Monk et al., 2009; reviewed in
Patra, Monk, & Engel, 2014). In the 1-day-old zebrafish embryo, the
expression pattern is very similar to that of the transcription factor
gene sox10, and adgrg6 expression in the ear and neural crest (but
F IGURE 1 Otic and myelination phenotypes in zebrafish adgrg6 mutants. (a) Phenotypically wild-type sibling (left panel, ventral view) and
homozygous adgrg6fr24−/− mutant (right panel, dorsal view), showing swollen otic vesicles (arrowhead). Anterior to the left. Note that head and
eye size, pectoral fins, pigmentation, and swim bladder inflation are all normal in the mutant. Scale bar, 200 μm. Images reproduced from Geng
et al., 2013. (b) In situ hybridization to myelin basic protein a (mbpa) transcripts in the trunk (top row) and to versican b (vcanb) in the ear (bottom
row). Lateral views; anterior to the left. Top row: expression of mbpa in Schwann cells of the posterior lateral line ganglion (pllg, arrowhead) and
posterior lateral line nerve (plln, arrow) is reduced in the hypomorphic tb233c allele, and lost altogether in the strong fr24 allele. The blurred stain
to the left in each image is expression in the central nervous system, which is unaffected in the mutants. Scale bar, 100 μm. Images reproduced
from Geng et al., 2013. Bottom row: strong expression of vcanb in the ear persists abnormally in adgrg6 mutants. Scale bar, 50 μm. dpf, days post
fertilization. Images reproduced from Diamantopoulou et al., 2019
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not in the heart) is reduced in sox10−/− mutants, suggesting that
Sox10 may be an upstream regulator of adgrg6 expression in these
tissues (Geng et al., 2013). In mammals, Adgrg6 is known to be
expressed in multiple tissues, including in the adult (Mogha
et al., 2016; Musa et al., 2019; Patra et al., 2014; Waller-Evans
et al., 2010).
The zebrafish adgrg6 mutations identified or generated to date
form an allelic series (Table 1) that has helped to dissect protein
function. The different variants include hypomorphic missense
mutations involving single amino acid changes in the transmem-
brane domain, which have been exploited in chemical screening
experiments (see below), and point mutations that introduce stop
codons early in the coding sequence, resulting in stronger ear and
myelination defects (Figure 1). However, even strong adgrg6 muta-
tions in zebrafish are homozygous viable, unlike in the mouse,
where targeted disruption of Adgrg6 is lethal before or soon after
birth (Monk et al., 2011; Waller-Evans et al., 2010). Although this
may reflect differences in Adgrg6 function between the two spe-
cies, the effects of complete deletion of the zebrafish gene have not
yet been demonstrated. It is also possible that the murine gene,
which is expressed in the placenta, has a role in the development of
extraembryonic tissues, which may contribute to the observed
lethality in mutants (Waller-Evans et al., 2010).
Given the importance of ADGRG6 in the myelination of the
PNS, and its dynamic expression during development and in adult
tissues, it is not surprising that ADGRG6 also has a role in human
disease. Evidence associating ADGRG6 variants with a wide range
of human pathologies, including both rare congenital conditions
and more common disorders, is accumulating from family studies,
GWAS data, RNA expression profiling studies, and animal models.
In this review, we highlight some of the recent advances in
Adgrg6 research, with a focus on the zebrafish model. We illus-
trate how the use of a suite of genetic, transgenic, imaging, and
gene editing tools, together with small molecule screening
approaches, make the zebrafish such a versatile model for the dis-
section of gene function, leading to new insights into the biology
of the Adgrg6 receptor and the disorders that can result from its
loss of function.
2 | THE ADGRG6 GENE AND PROTEIN
2.1 | Adgrg6 gene structure and alternative splicing
Although aGPCRs are found throughout the metazoa, Adgrg6 has no
orthologue in the commonly used invertebrate model organisms Dro-
sophila and C. elegans, the invertebrate chordates Ciona and amphioxus,
or in jawless vertebrates such as lamprey and hagfish (Waller-Evans
et al., 2010; ensembl.org GRCz11; Yates et al., 2019). The Adgrg6 gene
thus appears to be specific to jawed vertebrates, and is evolutionarily
conserved between teleost fish, amphibians, reptiles, birds, and mammals
(ensembl.org GRCz11). Within the aGPCR class, Adgrg6 is most closely
related to secretin-like GPCRs (reviewed in Patra et al., 2014; Scholz,
Langenhan, & Schöneberg, 2019). The zebrafish adgrg6 gene has
26 exons and spans almost 90 kb. Unlike many zebrafish genes, which
have two isoforms as a result of a teleost whole-genome duplication
event (Meyer & Schartl, 1999), zebrafish adgrg6 has a 1:1
correspondence—and 50% nucleotide identity—with the orthologous
human gene ADGRG6. The zebrafish and human Adgrg6 proteins also
show nearly 50% identity at the amino acid level, with the highest levels
of conservation in the 7-transmembrane domain and the CUB domain of
the ECR (Leon et al., 2020; ensembl.org GRCz11; Yates et al., 2019).
Alternative splicing is a feature of aGPCR genes (Salzman
et al., 2016). The expression of multiple isoforms, particularly of the
ECR, is thought to influence mechanical interactions with binding part-
ners, enhance receptor versatility and offer a regulatory mechanism for
receptor activity (Bjarnadóttir et al., 2007). The human and zebrafish
ADGRG6 genes are known to have four main alternative splice forms
(Moriguchi et al., 2004; Patra et al., 2014). These include inclusion
(S1 form, also known as +ss) or exclusion (S2 form, −ss) of the short
exon 6, which codes for 23 amino acids in the zebrafish Adgrg6 ECR
(Patra et al., 2014). In addition, the presence or absence of the penulti-
mate exon results in a frameshift that alters the coding sequence for
the intracellular C-terminal domain, which could potentially influence
downstream signaling events. Adhesion GPCRs in general are found to
have a high level of somatic mutations (Kan et al., 2010; O'Hayre
et al., 2013) and the human ADGRG6 gene in particular has numerous
variants (35,447 variants; ADGRG6-201 transcript, Yates et al., 2019).
TABLE 1 List of key zebrafish adgrg6 mutations
Mutation Amino Acid Domain Reported phenotype Reference
stl47 45+3, N68K, fs*28 CUB ear, radial sorting, PNS myelination (Petersen et al., 2015)
stl464 D134A, F135A CUB ear & PNS myelination (Leon et al., 2020)
fr24 L463* SEA ear & PNS myelination (Geng et al., 2013)
st49 Y782* GAIN ear & PNS myelination (Monk et al., 2009; Pogoda et al., 2006)
vu39 W804* GPS ear & PNS myelination (Geng et al., 2013)
stl215 4G831, I832 Stachel ear & PNS myelination (Liebscher, Schön, et al., 2014)
st63 C917Y TM2 PNS myelination (Monk et al., 2009; Pogoda et al., 2006)
tb233c I963N TM4 ear & PNS myelination (Geng et al., 2013; Whitfield et al., 1996)
tk256a P969L TM4 ear & PNS myelination (Geng et al., 2013; Whitfield et al., 1996)
Amino acid sequence and numbering are based on the reference sequence NM_001163291.2, with the exception of W804, which was reported as C804
in the reference sequence (see discussion in Geng et al. 2013). N68 was reported as Q68 in Petersen et al. 2015. Italic text indicates amino acid identity or
similarity with the human protein. Abbreviations: 4, deletion; fs, frame shift; see Figure 2 for domain name abbreviations.
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2.2 | Adgrg6 protein structure
Current models for the zebrafish Adgrg6 protein structure are shown
in Figure 2. During biosynthesis, autoproteolytic cleavage at the GPCR
Proteolysis Site (GPS) in the GAIN domain separates the protein into
N- and C-terminal fragments (NTF, CTF), which can remain non-
covalently associated at the membrane (Araç et al., 2012). The NTF is
composed of structural domains including the Complement C1r/C1s,
Uegf and Bmp1 (CUB), Pentraxin (PTX), and Hormone Receptor
(HormR) domains (Araç et al., 2012; Moriguchi et al., 2004), together
with a recently identified sperm protein, enterokinase and agrin (SEA)
domain (Leon et al., 2020). The SEA domain contains a furin cleavage
site in the human and mouse protein that is not conserved in zebrafish.
Like other aGPCRs, Adgrg6 undergoes post-translational modifications
including N-linked glycosylation of the ECR, which is thought to con-
tribute to the adhesive properties of the NTF (Langenhan, Aust, &
Hamann, 2013; Leon et al., 2020; Patra et al., 2014).
Determining the structure of the receptor, and in particular that
of the ECR, is fundamental to understanding its mechanism of action.
The crystal structure of the zebrafish Adgrg6 ECR is one of only four
aGPCR protein structures determined to date (Leon et al., 2020; Ping
et al., 2021; Salzman et al., 2016; Vakonakis, Langenhan, Prömel,
Russ, & Campbell, 2008), and has highlighted how conformational
changes of the ECR might regulate receptor activity. Crystallization of
the zebrafish Adgrg6 ECR and analysis with a range of imaging tech-
niques has revealed that the S2 form adopts a closed conformation, in
which the CUB domain interacts with the HormR domain (Figure 2b)
(Leon et al., 2020). This closed configuration is dependent on the pres-
ence of a proposed Ca2+ binding site within the CUB domain, together
with a disulfide-stabilized loop between the SEA and PTX domains.
The loop inserts between the CUB and HormR domains, stabilizing
their interaction (Leon et al., 2020). The 23-amino-acid linker in the
S1 form appears to disrupt the stability of the CUB-HormR interac-
tion, and the S1 ECR shows a variety of conformations, indicating an
ability to switch between an open and closed state (Figure 2c) (Leon
et al., 2020). This mobility translates to an increase in Adgrg6 signaling
in comparison with the basal activity associated with the closed iso-
form in an in vitro cAMP assay (Leon et al., 2020).
An intact Ca2+-binding site is also necessary for optimal receptor
function. A conserved aspartate residue co-ordinates a calcium ion in
Ca2+-binding CUB domains from different aGPCRs (Gregory, Thielens,
Arlaud, Fontecilla-Camps, & Gaboriaud, 2003). Disruption of the site
in the zebrafish Adgrg6 protein, by CRISPR/Cas9-mediated replace-
ment of both D134 and F135 residues with alanines, induces ear and
myelination defects similar to those observed in a strong loss-of-
function adgrg6 mutant (Leon et al., 2020). In the crystallized ECR, dis-
ruption of the Ca2+-binding site resulted in an open configuration, but
despite this, the S1 Adgrg6 isoform was unable to mediate an increase
in cAMP accumulation above basal levels (Leon et al., 2020). These
findings propose a complex mechanism by which the ECR may regu-
late Adgrg6 function, with an intact Ca2+-binding site and the
23-amino acid linker being necessary to trigger a boost in Adgrg6
signaling.
2.3 | Adgrg6 ligands and mechanosensing
The multiple domains in the long ECRs of aGPCRs provide the oppor-
tunity to bind to many different partners. Studies in a range of model
systems and contexts, including morpholino phenocopy and mutant
rescue experiments in the zebrafish, indicate that the Adgrg6 NTF
interacts with the ECM components Collagen IV (Paavola et al., 2014)
and Laminin-211 (Petersen et al., 2015), and the flexible tail residues
23–50 of the Prion protein (PrP23-50) (Küffer et al., 2016) (Figure 2d).
However, it is not fully understood how Adgrg6 and these natural
ligands operate at the cell membrane in vivo. Collagen IV and the
Prion protein appear to mediate cAMP accumulation through binding
to the Adgrg6-NTF directly (Küffer et al., 2016; Paavola et al., 2014).
However, application of purified Laminin-211 to cells transfected with
human ADGRG6 resulted in an unexpected decrease in cAMP accu-
mulation, attributed to an inhibition of basal signaling activity
(Petersen et al., 2015). In this experimental context, receptor activa-
tion required the application of force, by sample vibration, to mimic
the in vivo environment at the cell membrane (Petersen et al., 2015).
These observations suggest a variety of mechanisms through which
NTF binding partners can activate Adgrg6 signaling, and a potential
role for Adgrg6 in mechanosensing. Indeed, a study analyzing expres-
sion domains of a LacZ reporter for Adgrg6 expression in the mouse
has highlighted its predominant expression in mechanosensing tissues
(Musa, Cazorla-Vázquez, et al., 2019).
Adapting natural ligands as agonists of the Adgrg6 signaling path-
way could have exciting therapeutic potential for human diseases
involving disruption of ADGRG6 function. However, recent work to
develop the Prion protein (PrP) as an Adgrg6 agonist has proved chal-
lenging. The application of a stable Adgrg6-activating PrP-based mole-
cule failed to rescue a peripheral demyelinating neuropathy in PrP
knock-out mice, and transcriptomic data suggested that the rescuing
agent might itself be myotoxic (Henzi et al., 2020). Further identifica-
tion of NTF ligands will be critical in teasing out the underlying mech-
anisms leading to Adgrg6 activation. However, natural ligands may
not present a viable approach for therapeutic design due to their
widespread effects in vivo.
2.4 | Tethered agonist signaling: Autoactivation of
the Adgrg6 receptor
Early aGPCR studies highlighted that the NTF-CTF interaction at the
cell membrane provides an inhibitory control mechanism to limit recep-
tor signaling through G proteins (Okajima, Kudo, & Yokota, 2010;
Paavola, Stephenson, Ritter, Alter, & Hall, 2011; Ward et al., 2011). Uti-
lizing cAMP assays as a measure of ADGRG6 activity, Liebscher
et al. (2014) uncovered a tethered peptide agonist, terming it the “Sta-
chel” (“stinger”) sequence. The peptide is located at the N-terminal end
of the CTF, where it is embedded in beta sheets of the GAIN domain
(Figure 2) (Araç et al., 2012; Beliu et al., 2021). Although direct binding
has not yet been visualized, in vivo treatment of hypomorphic
adgrg6st63 zebrafish larvae with a synthetic 16-amino-acid Stachel
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F IGURE 2 Schematic models of zebrafish Adgrg6 protein structure and mechanism of activation. (a) Zebrafish Adgrg6 protein sequence and
domain organization, drawn to scale: signal peptide (SP), Complement C1r/C1s, Uegf, BMP1 (CUB), Pentraxin (PTX), Sperm protein, Enterokinase
and Agrin (SEA), hormone receptor (HormR), GPCR autoproteolysis-inducing (GAIN), Stachel sequence (S) and 7-pass transmembrane (7TM,
magenta) domains. The sequence of Adgrg6 splice isoforms is shown below the diagram: S1, including exon 6 (+SS, pink), and the short (α) and
long (β) isoforms resulting from inclusion or exclusion, respectively, of exon 25 (amino acid sequence in blue; splice site in red). The two cysteine
residues (C369, C375) that form a bond in the linker between PTX and SEA domain are shown in amber. Cleavage sites are highlighted by dotted
lines: GPCR autoproteolytic site (GPS, black), and position of furin cleavage site in mammalian ADGRG6 (f, green). Positions of widely studied
zebrafish mutations are shown above the diagram: truncating (nonsense) mutations in red; missense mutations in black. (b) Structure of Adgrg6
S2 isoform in closed conformation (not to scale). Domains correspond to those illustrated in (b); Ca2+ − binding site (green) within CUB domain,
cell membrane (gray). (c) Structure of Adgrg6 S1 isoform in open conformation. (d) Overview of potential Adgrg6 Stachel activation mechanism
(not to scale). Tethered Stachel sequence (amber star) self-activates Adgrg6 following removal of NTF. The NTF is also thought to signal in trans
(not shown). Known Adgrg6 NTF ligands (dashed shapes) include Collagen IV (pink, Col4), prion protein flexible tail (PrPFT, green), and Laminin-
211 (Lam211, turquoise). Signaling is transduced by various G protein α subunits activating intracellular pathways, elucidated from zebrafish
Adgrg6 studies (light blue) and mouse or human ADGRG6 studies (light red). Diagrams are adapted from (Leon et al., 2020); the figure summarizes
findings from this study and from (Geng et al., 2013; Küffer et al., 2016; Liebscher, Schön, et al., 2014; Lizano, Hayes, & Willard, 2021; Moriguchi
et al., 2004; Paavola, Sidik, Zuchero, Eckart, & Talbot, 2014; Patra et al., 2013; Petersen et al., 2015)
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peptide has been shown to mediate some restoration of Schwann cell
mbp expression in the PNS (Liebscher, Schön, et al., 2014). A Stachel
sequence has since been identified in multiple other aGPCRs (Demberg,
Rothemund, Schöneberg, & Liebscher, 2015; Stoveken, Hajduczok,
Xu, & Tall, 2015), suggesting it may be a common mechanism of action.
Two different models have been proposed for Stachel activation
of signaling. The first relies on the physical removal of the NTF—
through ligand interactions—to expose the tethered agonist, enabling
it to bind to the active site of the CTF and self-activate receptor sig-
naling (Liebscher, Schön, et al., 2014; Petersen et al., 2015). However,
a recent study using molecular dynamic simulations of aGPCRs has
proposed an alternative mechanism, in which the Stachel sequence is
transiently exposed through structural flaps within the GAIN domain,
following moderate movements (Beliu et al., 2021). Although not con-
firmed for Adgrg6, this notion could explain the basal activity of
Adgrg6 that is associated with the S2 isoform (Leon et al., 2020).
Stachel-independent activation of aGPCRs has also been detected
by multiple groups (Kishore, Purcell, Nassiri-Toosi, & Hall, 2016;
Salzman et al., 2017). Cells expressing a mutant isoform of ADGRG1
(H381S), defective in GPS autoproteolysis, exhibit an increase in sig-
naling following exposure to monobody ligands, a response that is
unaffected by disruption of the Stachel sequence (Salzman
et al., 2017). Furthermore, cells expressing an engineered form of
ADGRB1 lacking the Stachel peptide exhibit differential signaling
behavior, including elevated TGFα shedding, in comparison with the
intact receptor (Kishore et al., 2016). Exploiting equivalent Adgrg6
mutant isoforms may reveal further evidence of this mechanism
among aGPCRs and in which tissues or developmental contexts differ-
ent mechanisms apply.
2.5 | Adgrg6 coupling to G proteins
Initial studies to identify the G protein or proteins that couple to
zebrafish Adgrg6 showed that the myelination defects in adgrg6st49
mutants could be rescued by treatment with forskolin, an adenylyl
cyclase agonist that raises intracellular cAMP levels (Monk
et al., 2009). The ear phenotype in adgrg6tb233c mutants can also be
ameliorated by treatment with either forskolin or 3-isobutyl-
1-methylxanthine (IBMX), a phosphodiesterase inhibitor that prevents
cAMP degradation (Diamantopoulou et al., 2019; Geng et al., 2013).
These findings suggest that Adgrg6 couples to a Gαs signaling path-
way in both Schwann cells and in the ear (Figure 2d). Coupling to Gαs
has since been confirmed by several groups by detecting changes in
intracellular cAMP levels following expression of human ADGRG6
(Liebscher, Schön, et al., 2014; Paavola et al., 2014; Petersen
et al., 2015). Nevertheless, this may not represent the full picture as
aGPCRs are well-known to signal through multiple G-protein path-
ways (reviewed in Langenhan, 2019). Application of a novel
enterokinase-activated tethered ligand system of ADGRG6 not only
confirmed coupling to Gαs, but also demonstrated stimulation of
reporters for serum response factor (SRF) and serum response ele-
ment (SRE), indicating coupling to Gα12/13 and Gαq/11 pathways,
respectively (Lizano et al., 2021). However, a study utilizing chimeric
G proteins concluded that the human receptor can couple to Gαs and
Gαi, but not Gαq (Mogha et al., 2013). Given the evidence, a complex
interplay of multiple signaling pathways is likely to be associated with
the Adgrg6 receptor in vivo.
2.6 | Signaling via the Adgrg6 N-terminal fragment
The NTF produced by autoproteolytic cleavage of Adgrg6 at the GPS,
or potentially through furin cleavage of the human or mouse protein,
has been shown to act in trans, independently of the CTF. Initial stud-
ies of Adgrg6 knock-out mice uncovered a delay in radial sorting of
peripheral axons by Schwann cells, suggesting a role for Adgrg6 in this
process (Monk et al., 2011). Axonal sorting deficiencies were con-
firmed in zebrafish by analyzing adgrg6stl47 mutants, which predict a
protein with a truncated CUB domain (Petersen et al., 2015). More-
over, the stl47 mutants were unresponsive to forskolin treatment,
suggesting that axonal sorting materializes independently of the
canonical G-protein-coupled signaling associated with the Adgrg6
CTF. Laminin-211 was identified as a ligand of the Adgrg6 NTF in axo-
nal sorting, and multiple zebrafish adgrg6 mutant alleles were used to
characterize this interaction (Petersen et al., 2015). Given that Colla-
gen IV can also bind the NTF (Paavola et al., 2014), and that Col4a1
mouse mutants display peripheral radial sorting defects (Labelle-
Dumais et al., 2019), it is likely that Collagen IV performs a similar
function to Laminin-211 in this context in the mouse.
Further evidence for the NTF acting in a cAMP-independent
manner comes from studies in mice, where conditional disruption of
Adgrg6 in chondrocyte lineages results in skeletal abnormalities that
mimic human disorders, as discussed in Section 3 below. Treatment of
Adgrg6 conditional knock-out mice with the phosphodiesterase inhibi-
tor Rolipram, which would be expected to restore cAMP signaling
downstream of the receptor, was unable to rescue the skeletal pheno-
type, suggesting alternative signaling pathways may be required in
mammalian chondrocytes (Karner, Long, Solnica-Krezel, Monk, &
Gray, 2015). In another study, over-expression of the Adgrg6 NTF
(S1 isoform) was reported to delay ossification of human mesenchy-
mal stem cells in vitro; the authors propose that differential expres-
sion of ADGRG6 or its isoforms could contribute to the abnormal
curvature of the spine in patients with Adolescent Idiopathic Scoliosis
(Xu et al., 2019) (see also Section 3.4).
The Adgrg6 NTF has also been implicated in heart development.
Adgrg6 is expressed in the mouse and zebrafish heart (Geng
et al., 2013; Monk et al., 2011; Moriguchi et al., 2004; Patra
et al., 2013), and homozygous mutant mice have cardiac
hypotrabeculation defects (Patra et al., 2013). However, cardiovascu-
lar defects are not obvious in most of the zebrafish mutant alleles ana-
lyzed to date (Geng et al., 2013; Leon et al., 2020; Monk et al., 2009),
and adgrg6 homozygous mutant fish are adult viable. By contrast,
morpholino-mediated knock-down of adgrg6 was reported to result in
a similar hypotrabeculation defect to that in the mouse mutants,
which could be rescued by injection of mRNA coding for the NTF
(Patra et al., 2013). The reported heart defects in zebrafish morphants
could be the result of an off-target effect of the morpholino, but it is
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also possible that genetic compensation—now well characterized for
other zebrafish genes (El-Brolosy et al., 2019)—acts to mask any heart
phenotype in the mutants. Nevertheless, the mutant alleles with no
overt heart defects still predict that a truncated NTF could be pro-
duced. The most severe truncating allele, stl47, predicts a deletion of
most of the NTF; these mutants do display heart oedema (Petersen
et al., 2015), and a recent report suggests they also have
hypotrabeculation (Srivastava et al., reviewed in Morgan et al., 2019).
A separate report found Adgrg6 expression downstream of Notch sig-
naling in both trabeculation and compaction of the mouse heart, with
a reduction in cardiac adgrg6 expression in the zebrafish Notch path-
way mutant mind bomb (E3 ubiquitin ligase) (D'Amato et al., 2016). In
addition, injection of zebrafish embryos with a potential post-
transcriptional regulator of Adgrg6, miR-27b, produced the same
hypotrabeculation phenotype as in adgrg6 morphants (Musa,
Srivastava, Petzold, Cazorla-Vázquez, & Engel, 2019). Given these
observations, a detailed analysis of the cardiac phenotype in the dif-
ferent zebrafish alleles will be important to confirm any role for
Adgrg6 in zebrafish heart trabeculation.
3 | ADGRG6 AND HUMAN DISEASE
3.1 | ADGRG6 coding sequence mutations and
inherited disease
Many of the mutations in ADGRG6 associated with human disease
(Table 2) affect residues that are conserved in zebrafish. The first
studies to implicate ADGRG6 in human disease corroborated the
myelination defects discovered in zebrafish and mouse mutants. Pro-
bands from three consanguineous families with Lethal Congenital
Contracture Syndrome 9 (LCCS9), a rare form of Severe
Arthrogryposis Multiplex Congenita (AMC), were found to harbor dif-
ferent homozygous recessive mutations in the ADGRG6 coding
sequence (Ravenscroft et al., 2015). AMC is known to have multiple
causes that can be musculoskeletal or neuronal in origin. Contractures
were observed in the limbs of mouse Adgrg6 mutants that lack
myelination of the peripheral nerves (Monk et al., 2011). In the Rav-
enscroft et al. (2015) study, a lack of MBP staining was also observed
in the intramuscular nerves, confirming that a myelination defect
underlies the phenotype. In a separate study of an Iranian family with
autosomal recessive Intellectual Disability, whole exome sequencing
identified a strong candidate missense mutation in the transmembrane
domain of ADGRG6. The two patients survived beyond puberty and
displayed a number of common features with LCCS9, including con-
tractures (Hosseini et al., 2018).
3.2 | Identification of ADGRG6 variants through
GWAS and RNA sequencing
Recent Genome-Wide Association Studies (GWAS) and RNAseq stud-
ies have found many associations with variants in both coding and
non-coding regions of the human ADGRG6 locus that may provide
clues to ADGRG6 function in disease (see https://www.ebi.ac.uk/
gwas/genes/ADGRG6 for a comprehensive list). One example is a
missense mutation in the ADGRG6 transmembrane region, R1057Q,
that has been linked to severe periodontitis in a cohort of Japanese
patients (Kitagaki et al., 2016). In vitro studies found that the amino
acid change reduced cAMP accumulation compared with wild-type
ADGRG6; expression of downstream target genes (Bmp2, ID2 and
ID4) and cytodifferentiation were affected. This work implicates
ADGRG6 in the homeostasis of periodontal ligament tissues, making
the R1057Q mutation a strong candidate as a functional cause of the
disease.
The mammalian ADGRG6 gene is widely expressed in the lung
(Musa, Cazorla-Vázquez, et al., 2019) and evidence is increasing for
the association of ADGRG6 variants in both coding and intronic
regions with different aspects of lung function, including chronic
obstructive pulmonary disease (COPD) (Hancock et al., 2010; Jack-
son et al., 2016; Soler Artigas et al., 2015; Wilk et al., 2012). One of
these variants, resulting in the missense mutation S123G, was also
identified in Andean people living at altitude, suggesting it may be
involved in the physiological adaptation to hypobaric hypoxia
TABLE 2 List of key ADGRG6 coding variants associated with human disease conditions
Disease/condition Amino acid Domain Mutation (SNP reference) Reference
LCCS9 R7* SP Nonsense homozygous (Ravenscroft et al., 2015)
LCCS9 Q716T, fs*16 GAIN Duplication c2144dup homozygous (Ravenscroft et al., 2015)
LCCS9 V769E GAIN Missense homozygous (Ravenscroft et al., 2015)
Intellectual disability W1088C TM6–7 extracellular loop Missense homozygous (Hosseini et al., 2018)
Periodontitis R1057Q TM5–6 intracellular loop Missense (rs536714306) (Kitagaki et al., 2016)
COPD S123G, K230Q CUB, PTX Missense (rs17280293) (Terzikhan et al., 2018)
Hypobaric hypoxia adaptation S123G CUB Missense (rs17280293) (Eichstaedt et al., 2017)
Pulmonary function K230Q PTX Missense (rs11155242) (Hancock et al., 2010)
Note: Amino acid sequence and numbering are based on the reference sequence NM_198569.3. Italic text indicates amino acid identity or similarity with
the zebrafish protein.
Abbreviations: COPD, chronic obstructive pulmonary disease; fs, frame shift. See Figure 2 for domain name abbreviations.
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(Eichstaedt et al., 2017). A separate analysis of this variant found that
expression of ADGRG6 in human lung tissue was decreased in COPD
patients and in individuals with decreased pulmonary ventilatory
function, suggesting this variant may also be functional (Terzikhan
et al., 2018).
ADGRG6 variants and transcriptional changes have also been
associated with various human cancers. A transcriptomic analysis of
772 GPCRs in 148 acute myeloid leukemia (AML) samples,
encompassing different subgroups, identified ADGRG6 as one of
19 down-regulated GPCRs, with others including the closely related
ADGRG1 and SMO (Maiga et al., 2016). However, ADGRG6 was up-
regulated in specific MLL translocations, suggesting ADGRG6 as a
candidate disease-specific therapeutic target in these sub-groups
(Maiga et al., 2016). The ADGRG6 locus also contains a highly muta-
ble palindromic motif in intron 6 that is found in 2.7% of breast can-
cers (Nik-Zainal et al., 2016) and in more than 45% of bladder
cancers (Garinet et al., 2019). ADGRG6 is expressed in the bladder
and mutations in the intron 6 motif correlated with an increase in
ADGRG6 expression and a poor prognosis in one study
(Wu et al., 2019). Increased ADGRG6 expression also correlated with
an increase in tumor angiogenesis (Wu et al., 2019), supporting pre-
vious evidence that ADGRG6 may have a role more generally in
angiogenesis via the VEGF signaling pathway (Cui et al., 2014;
Stehlik et al., 2004).
3.3 | Role of ADGRG6 in the skeleton
Noncoding variants at the human ADGRG6 locus are associated with
different aspects of musculoskeletal development, including height
(Soranzo et al., 2009; J. Zhao et al., 2010) and adolescent idiopathic
scoliosis (AIS) (Karner et al., 2015; Kou et al., 2013, 2018; Qin
et al., 2017; J. F. Xu et al., 2015). AIS is very common, affecting up to
3% of children in the UK (Lenssinck et al., 2005). In mice, Adgrg6 is
expressed in chondrogenic lineages of the axial skeleton (Liu
et al., 2019). Adgrg6 knock-out mice are shorter than their WT litter-
mates and have spinal abnormalities (Monk et al., 2011). Although this
suggests a functional role in skeletal development, scoliosis can occur
secondary to neuropathy or can be co-morbid with joint contractures,
as is found in AMC (Ravenscroft et al., 2015).
To address whether skeletal defects are the underlying cause of
the AIS phenotype in Adgrg6 mutants, two studies used tissue-specific
deletion of Adgrg6 in mice (Karner et al., 2015; Sun et al., 2020). Con-
ditional knock-out of Adgrg6 in osteoblasts did not result in scoliosis;
instead, mutant mice showed delayed ossification and reduced growth
(Sun et al., 2020), supporting a role for ADGRG6 in influencing body
length. This study identified Collagen IV as the Adgrg6 ligand and
found that treatment with forskolin could partially rescue the pheno-
type (Sun et al., 2020). In contrast to the deletion of Adgrg6 in osteo-
blasts, deletion of Adgrg6 in chondrocyte lineages of the spine in mice
resulted in abnormalities of the intervertebral disc (IVD), including
mechanical stiffening and eventual disc herniation, or scoliosis,
depending on the transgenic driver used (Karner et al., 2015; Liu
et al., 2019). Expression of Stat3, a gene known to be upregulated in
disc degeneration and osteoarthritis, was increased (Liu et al., 2019).
A STAT3 inhibitor used to treat osteoarthritis protected against the
defect, suggesting that ADGRG6 is a potential therapeutic target for
IVD degeneration. Other studies also implicate Adgrg6 in AIS pathol-
ogy (Xu et al., 2019; Xu, Lin, et al., 2019), but analysis of the ADGRG6
transcript expression profile in both normal and AIS patient tissue is
needed to confirm these results. In the zebrafish, adgrg6 is expressed
in the developing craniofacial and axial skeleton (Geng et al., 2013;
Glenn & Talbot, 2013). Delayed ossification and a slight reduction in
body length has also been reported in zebrafish adgrg6 morphants
(Kou et al., 2013); however, a difference in body length has not been
reported in any of the zebrafish adgrg6 mutant alleles. Further work is
needed to determine if Adgrg6 plays a role in body length and IVD
development in fish.
3.4 | Role of Adgrg6 in remyelination and
regeneration
Unlike mammals, zebrafish are able to regenerate a wide range of adult
tissues following injury, including the spinal cord, fin and heart
(reviewed in Cigliola, Becker, & Poss, 2020; Roehl, 2018; Sanz-Mor-
ejón & Mercader, 2020). To date, most studies of Adgrg6 have focused
on a role for the receptor in the initial development of Schwann cell
myelination, rather than the maintenance or repair of myelination at
adult stages (Glenn & Talbot, 2013). However, expression of Adgrg6 is
maintained and required in adult mammalian and zebrafish Schwann
cells (Mogha et al., 2013; Monk et al., 2009), raising the possibility of a
role for the receptor in peripheral nerve remyelination and regeneration
following injury. Mogha et al. (2016) generated a Schwann-cell-specific,
tamoxifen-inducible Adgrg6 knock-out mouse model and performed a
crush injury of the sciatic nerve. Twenty-one days after nerve crush, the
tamoxifen-injected mice showed significantly impaired sciatic nerve
remyelination and persistent myelin debris, in comparison with control-
injected animals (Mogha et al., 2016). These findings suggested that
Adgrg6 is needed autonomously in mammalian Schwann cells for
remyelination, but is also required non-autonomously for recruitment of
macrophages to clear damaged tissue (Mogha et al., 2016). Furthermore,
length measurements of the longest regenerating axons (from the crush
site) revealed that axon regeneration is greatly impaired in mutant mice
compared with controls, proposing another non-autonomous role for
Adgrg6 in peripheral axon regeneration following nerve injury (Mogha
et al., 2016). Adgrg6 is both expressed and required in non-myelinating
terminal Schwann cells for re-innervation following nerve crush at the
neuromuscular junction, where it also has a non-cell-autonomous role in
the immune response after injury (Jablonka-Shariff, Lu, Campbell,
Monk, & Snyder-Warwick, 2020). In the zebrafish, a study using the
stl47 allele suggests that Adgrg6 is not required for the initial changes in
Schwann cell morphology in response to peripheral motor nerve tran-
section (Ducommun Priest, Navarro, Bremer, & Granato, 2019). How-
ever, a full analysis of nerve regeneration in zebrafish adgrg6 mutants
has not yet been performed, to our knowledge.
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4 | ADGRG6 AND DRUG DISCOVERY
4.1 | GPCRs as druggable targets
Compounds targeting GPCRs constitute a major class in the global market
share of therapeutic drugs, reflecting the diverse roles of these receptors
in cellular physiology, accessibility at the cell surface, and the presence of
binding pockets within their structure (Manglik & Kruse, 2017). Adhesion
GPCRs, however, are not represented as targets for licensed drugs, but
offer similar potential, given their role in human disease. There are many
challenges for aGPCR drug discovery, in part due to the multimodal
nature of aGPCRs, which have functions in different tissues, and the pos-
sibility of polypharmacology, due to structural similarities between
aGPCRs, with any drug identified potentially acting on multiple aGPCRs.
In particular, the gedunin class of partial agonists can also act on multiple
receptors (Stoveken, Larsen, Smrcka, & Tall, 2018).
Knowledge of the structure of the Adgrg6 ECR (Leon et al., 2020)
should facilitate drug design; however, the structure of the CTF, and
in particular of the pocket where the Stachel peptide binds, are still
uncharacterised. The Adgrg6 ECR has structural similarities with the
extendable ECR of the epidermal growth factor receptor (EGFR) (Leon
et al., 2020). Cetuximab, an anti-cancer monoclonal antibody drug,
targets the ECR of EGFR, preventing its extension to the active iso-
form (Li et al., 2005). Leon et al. (2020) speculate that the dynamic
Adgrg6 S1 ECR may be druggable through an equivalent approach to
modulate mechanosensory and/or signal transducing functions.
Although there are challenges for targeting ADGRG6, small molecule
modulators have potential for therapeutic use against many
ADGRG6-disease linked conditions, including cancers where ADGRG6
overexpression may contribute to the disease (see Section 3).
4.2 | Small modulators of GPCRs as biological tools
In addition to therapeutics, chemical ligands that bind directly with
the Adgrg6 protein could provide valuable tools to stabilize the recep-
tor in an active or inactive conformation, which could facilitate isola-
tion of the receptor in its in vivo conformation, or for the
manipulation of pathway activity. Agonist and antagonist compounds
are widely utilized as pharmacological tools to modulate the activity
of key developmental signaling pathways, including those of the
Hedgehog (Hh) and Wnt proteins, which signal via Smoothened and
Frizzled family GPCRs, respectively (reviewed in Agostino &
Pohl, 2020). A precedent for the translation of small molecules origi-
nally identified through developmental biological research to the clinic
is the Smoothened inhibitor vismodegib, now a treatment for basal
cell carcinoma (Ingham, 2018).
4.3 | Zebrafish screens for small molecule
modulators of Adgrg6 pathway activity
Zebrafish present an excellent whole-animal model for precision med-
icine and are amenable to medium- and high-throughput small
molecule screening approaches (reviewed in Baxendale, van Eeden, &
Wilkinson, 2017; Lam & Peterson, 2019). The multimodal nature of
aGPCRs and the potential for polypharmacology present problems for
traditional in vitro drug discovery pipelines. Adhesion GPCR function
is very likely to be context-dependent, due to, for example, interac-
tions with the extracellular matrix and mechanosensing functions.
In vivo screening naturally provides these physiological contexts,
which are less likely to be recapitulated in an in vitro cell line-based
screening platform. The use of zebrafish drug screening approaches
also has the advantage of eliminating compounds with toxic or off-
target effects in the primary screen.
Several features have made the zebrafish Adgrg6 pathway partic-
ularly advantageous for interrogation with small-molecule-based
screens. Firstly, hypomorphic alleles—those with weak phenotypes—
are amenable to modulation in two directions: rescue of the pheno-
type or its further exacerbation (Figure 3). Hypomorphs may also
exhibit higher sensitivity to small-molecule-centered therapeutic
approaches, as a weaker phenotype can sometimes be rescued more
easily. Secondly, the available zebrafish adgrg6 mutants are homozy-
gous viable, allowing batches of 100% mutant embryos to be pro-
duced for screening assays. Thirdly, clear mRNA or transgene
expression changes in the mutant have enabled the development of
robust and reliable screening assays. Finally, the comparison of both
hypomorphic and strong alleles in secondary screens has allowed the
differentiation of different classes of hit compounds.
Two different screens have used these advantages in their
approach (Bradley et al., 2019; Diamantopoulou et al., 2019). Using
the expression of versican mRNA in the mutant ear as a phenotypic
readout of Adgrg6 pathway activity, Diamantopoulou et al. (2019)
identified several classes of small molecules that could rescue the otic
phenotype in adgrg6tb233c hypomorphic mutants, some of which also
rescued the myelination defect (Figure 3). The hit compounds
included colforsin (a forskolin derivative that raises cAMP levels), a
group of dihydropyridines, and a cluster of gedunin derivatives
(Diamantopoulou et al., 2019), some of which were independently
identified as modulators of human ADGRG1 (Stoveken et al., 2018).
Whereas colforsin was able to rescue both hypomorphic (tb233c) and
strong (fr24) alleles, validating association of Adgrg6 to Gαs, other hit
compounds were ineffective at rescuing the fr24 allele
(Diamantopoulou et al., 2019) (Figure 3). This latter class are of partic-
ular interest, as they may act directly at the level of the receptor. Fur-
ther work will be needed to test these compounds in cell-based cAMP
or Ca2+ immobilization assays to determine direct agonism for Adgrg6
(Liebscher, Ackley, et al., 2014; Lizano et al., 2021).
Bradley et al. (2019) monitored changes in mbp-driven trans-
gene expression in Schwann cells for their compound screen in
adgrg6st63 hypomorphic mutants. They identified apomorphine
hydrochloride, a dopamine receptor agonist, for its ability to induce
upregulation of mbp-driven GFP in adgrg6 mutants and to mediate
an increase in cAMP levels in Adgrg6-expressing cells (Bradley
et al., 2019). Differences in the hit molecules identified between
this and the Diamantopoulou et al. (2019) screen are likely to reflect
the different commercially-available compound collections that
were used, together with differences in the alleles used for
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screening and details of the screening assay design, including com-
pound concentration and exposure time. Clearly, each study has
yielded a rich resource of material for validation and further study.
A novel approach that could provide further support for the action
of apomorphine hydrochloride or other candidate compounds as
Adgrg6 agonists is to determine coupling of mini-G proteins to
Adgrg6 following treatment (Carpenter & Tate, 2016; Nehmé
et al., 2017). Such experiments would provide a direct measure of
Adgrg6 activity following small molecule treatments, as opposed to
the detection of downstream effector molecules, such as cAMP,
that can be modulated by potential compound agonism on adenylyl
cyclase.
Taken together, the research findings illustrate a space for multi-
faceted drug screening approaches that combine zebrafish phenotypic
strategies with in vitro cell-based assays to overcome the individual
limitations of each in identifying aGPCR modulators. The availability
of tailored technologies such as automated imaging for the zebrafish
larva is improving the throughput of zebrafish small molecule screens
(Bradley et al., 2019; Early et al., 2018). However, the lower-cost
semi-quantitative in situ hybridization approach also remains effective
(Diamantopoulou et al., 2019).
5 | CONCLUSIONS AND FUTURE
PERSPECTIVES
Recent research on Adgrg6 has led to a better understanding of this
complex receptor, including its structure, mechanism of action, and
roles in development and disease. Work in the zebrafish model has
made significant contributions to this research effort. Nevertheless,
many questions remain. For instance, we still need to know more
about upstream regulators, downstream targets, ligand-receptor bind-
ing and the different modes of signaling mediated by the tethered
agonist and the NTF. However, there are many areas for future
F IGURE 3 Design and proof-of-principle for a whole-animal compound screen to identify agonists of the zebrafish Adgrg6 pathway.
(a) Overview of screen pipeline. Batches of 100% homozygous embryos are dispensed into 96-well plates, with three embryos (biological
replicates) per well. Embryos are incubated in control and test compounds from a library of choice at an optimum time for rescue of the mutant
phenotype. Effects of compounds on gene expression are measured by semi-automated in situ hybridisation. (b) Example results from a two-part
in situ hybridization screen using the hypomorphic (adgrg6tb233c−/−) alelle. Here, an example hit compound (nifedipine, a dihydropyridine) reduces
vcanb expression in the ear (top panels) and restores mpba expression in Schwann cells of the lateral line nerves in the vicinity of the ear. Several
areas of mbpa expression are rescued, in particular that associated with the posterior lateral line ganglion (pllg, arrowhead). Lateral views; anterior
to the left, dorsal to the top. Abbreviations: allg, anterior lateral line ganglion; c, expression associated with the sensory cristae of the ear; DMSO,
dimethyl sulfoxide; dpf, days post fertilization; io, infraorbital ramus of the anterior lateral line nerve; pll-d, pll-v, dorsal and ventral rami of the
posterior lateral line nerve; pllg, posterior lateral line ganglion. Scale bars, 50 μm (top row); 50 μm (bottom row). (c) Use of hypomorphic and
strong alleles to differentiate hit compound classes in the vcanb expression assay. Effects of example compounds are shown. Colforsin, a forskolin
derivative, rescues both alleles efficiently, and is likely to act downstream of the pathway to raise cAMP levels. Carapin-8(9)-ene rescues the
hypomorph, but has no effect on the stronger fr24 allele. Compounds such as this may interact directly with the Adgrg6 receptor. Scale bar,
50 μm. Images reproduced from Diamantopoulou et al., 2019
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Adgrg6 research that play to zebrafish strengths in imaging, chemical
screening, and gene editing.
One area where recent advances in technology can contribute is
to understand the role that different adgrg6 splice forms play in differ-
ent developing tissues and how they lead to Adgrg6 protein diversity.
At least four splice variants have been reported for the human gene,
and it is likely RNAseq data will identify more. Determining when and
where different isoforms are expressed, and finding any changes in
expression in disease situations, is challenging. Use of single molecule
fluorescent in situ hybridization (smFISH) techniques, which are being
employed successfully in zebrafish (Soto et al., 2020; Stapel
et al., 2016) will enable a detailed analysis of different splice forms
and provide tissue-specific cellular localization of the transcripts.
Another area requiring further investigation is the potential role
of Adgrg6 as a mechano-sensor, and whether mechanosensation is a
key feature of Adgrg6 function in different tissues. It is interesting to
speculate that Adgrg6-mediated mechanosensing might have a similar
role in the outgrowth and fusion of epithelial projections in the devel-
oping ear, as in skeletal development or cardiac trabeculation. Many
similar genes and ECM molecules are expressed in all three organ sys-
tems and all are subject to mechanical forces. However, both heart
and cartilage formation are thought to require the Adgrg6 NTF and do
not appear to signal through the canonical cAMP pathway, whereas a
role for the NTF alone has not been determined in the inner ear.
Zebrafish are well suited to studying the mechanical contributions to
tissue morphogenesis in vivo; a recent relevant example tackles the
contribution of tension heterogeneity to cardiac trabeculation (Priya
et al., 2020). The development and use of tools for live imaging and
the measurement of mechanical forces in the zebrafish embryo are
pushing boundaries in this important area (Serwane et al., 2017; Shah
et al., 2019; Tlili et al., 2019; Tsai et al., 2020).
The pharmacological tools available for aGPCRs in general and
Adgrg6 in particular are currently very limited. Hit compounds identi-
fied from existing or new chemical screens could be used to target dif-
ferent aspects of Adgrg6 biology using zebrafish in vivo assays, and
could be developed into specific small molecule modulators of the
receptor. Here, existing studies have already provided promising
starting points, such as the gedunin class of molecules
(Diamantopoulou et al., 2019; Stoveken et al., 2018). Virtual screening
and in silico approaches used in conjunction with the existing and
future receptor structures will also be important in identifying novel
Adgrg6-binding molecules.
Optimization of CRISPR/Cas9 technologies for zebrafish continues
apace, with recent success in high-efficiency targeted integration
through homology-directed repair using DNA or single-stranded oligo-
nucleotide templates (Prykhozhij et al., 2018; Wierson et al., 2020) or
by direct base editing (see, for example, Rosello et al., 2021; Zhao,
Shang, Ying, Cheng, & Zhou, 2020). Such approaches, as already exem-
plified by targeted disruption of the zebrafish Adgrg6 Ca2+-binding site
(Leon et al., 2020), can be used to introduce specific human disease
mutations into the zebrafish gene or to create a humanized Adgrg6
gene in zebrafish, which will provide a valuable resource for ADGRG6
disease modeling and drug validation. Together, the multitude of
approaches possible in the zebrafish offers great promise for furthering
our understanding of the Adgrg6 signaling pathway, its roles in the
developing embryo, and its significance for human disease.
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